$CRTG
CORETEC GROUP INC. Stock $crtg

$crtg Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924008792 Filed on March 21, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$358.1K	$833.4K	$1.792M
YoY Change	3.14%	-13.24%	-15.99%
% of Gross Profit
Research & Development	$122.5K	$178.5K	$513.0K
YoY Change	9.43%	31.93%	-4.27%
% of Gross Profit
Depreciation & Amortization	$3.960K	$25.13K	$12.50K
YoY Change	66.88%	9.12%	83.79%
% of Gross Profit
Operating Expenses	$122.5K	$813.2K	$513.0K
YoY Change	9.43%	-25.45%	-4.27%
Operating Profit
YoY Change
Interest Expense	$44.52K	-$56.14K	$217.6K
YoY Change	-17.68%	3.05%	7.31%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$524.2K	-$869.3K	-$2.308M
YoY Change	3.32%	-24.1%	-19.41%
Income Tax
% Of Pretax Income
Net Earnings	-$524.2K	-$869.3K	-$2.308M
YoY Change	3.32%	-24.1%	-19.41%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00		-$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	301.4M	284.1M	277.7M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$115.1K	$524.0K	$524.0K
YoY Change	-94.08%	-77.76%	-77.76%
Cash & Equivalents	$115.1K	$524.0K
Short-Term Investments
Other Short-Term Assets	$88.29K	$132.7K	$132.7K
YoY Change	55.8%	16.18%	16.18%
Inventory
Prepaid Expenses	$88.29K	$132.7K
Receivables
Other Receivables
Total Short-Term Assets	$203.4K	$656.7K	$656.7K
YoY Change	-89.83%	-73.42%	-73.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$105.8K	$109.8K	$109.8K
YoY Change	48.84%	49.42%	49.43%
Goodwill	$166.0K	$166.0K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.550K	$4.550K	$4.550K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$1.080M	$1.105M	$1.105M
YoY Change	-4.25%	-4.02%	-4.03%
TOTAL ASSETS
Total Short-Term Assets	$203.4K	$656.7K	$656.7K
Total Long-Term Assets	$1.080M	$1.105M	$1.105M
Total Assets	$1.283M	$1.761M	$1.761M
YoY Change	-58.97%	-51.37%	-51.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$154.7K	$75.92K	$75.92K
YoY Change	-55.17%	-76.05%	-76.05%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$48.18K	$571.5K	$95.38K
YoY Change	55.92%	830.7%	55.34%
Long-Term Debt Due	$476.1K	$476.1K	$476.1K
YoY Change	602.78%
Total Short-Term Liabilities	$679.0K	$647.4K	$647.4K
YoY Change	52.99%	71.09%	71.09%
LONG-TERM LIABILITIES
Long-Term Debt	$1.010M	$1.004M	$1.004M
YoY Change	-25.95%	-29.05%	-29.05%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.010M	$1.004M	$1.004M
YoY Change	-25.95%	-29.05%	-29.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$679.0K	$647.4K	$647.4K
Total Long-Term Liabilities	$1.010M	$1.004M	$1.004M
Total Liabilities	$1.689M	$1.651M	$1.651M
YoY Change	-6.56%	-7.92%	-7.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.18M	-$18.65M
YoY Change	13.79%	14.12%
Common Stock	$60.27K	$56.82K
YoY Change	12.09%	5.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$405.1K	$110.1K	$110.1K
YoY Change
Total Liabilities & Shareholders Equity	$1.283M	$1.761M	$1.761M
YoY Change	-58.97%	-51.37%	-51.37%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$524.2K	-$869.3K	-$2.308M
YoY Change	3.32%	-24.1%	-19.41%
Depreciation, Depletion And Amortization	$3.960K	$25.13K	$12.50K
YoY Change	66.88%	9.12%	83.79%
Cash From Operating Activities	-$361.7K	-$609.0K	-$1.819M
YoY Change	-5.4%	23.75%	-1.62%
INVESTING ACTIVITIES
Capital Expenditures		$2.860K	$52.86K
YoY Change			-34.14%
Acquisitions
YoY Change
Other Investing Activities		$4.250K	$4.250K
YoY Change
Cash From Investing Activities		$1.390K	-$48.61K
YoY Change			-39.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$47.20K	115.2K	$35.23K
YoY Change	54.74%	59.2%	-84.83%
NET CHANGE
Cash From Operating Activities	-$361.7K	-609.0K	-$1.819M
Cash From Investing Activities		1.390K	-$48.61K
Cash From Financing Activities	-$47.20K	115.2K	$35.23K
Net Change In Cash	-$408.9K	-492.4K	-$1.832M
YoY Change	-0.96%	17.31%	7.98%
FREE CASH FLOW
Cash From Operating Activities	-$361.7K	-$609.0K	-$1.819M
Capital Expenditures		$2.860K	$52.86K
Free Cash Flow		-$611.8K	-$1.872M
YoY Change		24.33%	-2.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	564000	usd
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3864151	usd
CY2022	crtg	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1030	usd
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001375195
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1623021	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	301368572
CY2023	dei	Auditor Firm AuditorFirmId	483
CY2023	dei	Auditor Name AuditorName	HOGANTAYLOR LLP
CY2023	dei	Auditor Location AuditorLocation	Tulsa, Oklahoma
CY2023Q4	us-gaap	Cash Cash	523988	usd
CY2022Q4	us-gaap	Cash Cash	2356348	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	132680	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	114201	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	656668	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2470549	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109766	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	73462	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	824345	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	906975	usd
CY2023Q4	us-gaap	Goodwill Goodwill	166000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	166000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4550	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4550	usd
CY2023Q4	crtg	Assets Excluding Property And Equipment Noncurrent AssetsExcludingPropertyAndEquipmentNoncurrent	994895	usd
CY2022Q4	crtg	Assets Excluding Property And Equipment Noncurrent AssetsExcludingPropertyAndEquipmentNoncurrent	1077525	usd
CY2023Q4	us-gaap	Assets Assets	1761329	usd
CY2022Q4	us-gaap	Assets Assets	3621536	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	75918	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	316992	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	571451	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	61398	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	647369	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	378390	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1003816	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1414826	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1651185	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1793216	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0002
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0002
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	345000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	345000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	345000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	345000
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	69	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	69	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	284104032
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	284104032
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	268871202
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	268871202
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	56819	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	53772	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18706208	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18119792	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18652952	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16345313	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	110144	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1828320	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1761329	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3621536	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	512952	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	535837	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1791910	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2132996	usd
CY2023	us-gaap	Interest Expense InterestExpense	217564	usd
CY2022	us-gaap	Interest Expense InterestExpense	202751	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	2522426	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	2871584	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	214787	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	8260	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2307639	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2863324	usd
CY2022	crtg	Stock Issued During Period Value Issued For Liabilities StockIssuedDuringPeriodValueIssuedForLiabilities	60666	usd
CY2022	crtg	Stock Issued During Period Value Stock Options Exchanged For Common Shares StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4102	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	761695	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1828320	usd
CY2023	crtg	Stock Issued During Period Value Issued For Liabilities StockIssuedDuringPeriodValueIssuedForLiabilities	24213	usd
CY2023	crtg	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1250	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2307639	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	110144	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2307639	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2863324	usd
CY2023	us-gaap	Depreciation Depreciation	12503	usd
CY2022	us-gaap	Depreciation Depreciation	6803	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	82630	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	82629	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	65065	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	61660	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	564000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	761695	usd
CY2023	crtg	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	195901	usd
CY2022	crtg	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	-0	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	195	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	18479	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-19289	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-0	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-11793	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-20960	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	70563	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1818976	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1848892	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52862	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	80265	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4250	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48612	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-80265	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	122828	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	40046	usd
CY2023	crtg	Proceeds From Debt And Warrants Issued ProceedsFromDebtAndWarrantsIssued	156806	usd
CY2022	crtg	Proceeds From Debt And Warrants Issued ProceedsFromDebtAndWarrantsIssued	271194	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1250	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1030	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35228	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	232178	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1832360	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1696979	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2356348	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4053327	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	523988	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2356348	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	183767	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	132873	usd
CY2023	crtg	Stock Options Exchanged For Common Stock StockOptionsExchangedForCommonStock	0	usd
CY2022	crtg	Stock Options Exchanged For Common Stock StockOptionsExchangedForCommonStock	180	usd
CY2023	crtg	Stock Issued To Settle Liabilities From Services Received StockIssuedToSettleLiabilitiesFromServicesReceived	24213	usd
CY2022	crtg	Stock Issued To Settle Liabilities From Services Received StockIssuedToSettleLiabilitiesFromServicesReceived	60666	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	266442697
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	254942697
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17425	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6803	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109766	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	73462	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	587662	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	505032	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	824345	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	906975	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	571451	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	61398	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1003816	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1414826	usd
CY2023	crtg	Amortization Associated With Commitment Fee AmortizationAssociatedWithCommitmentFee	17348	usd
CY2022	crtg	Amortization Associated With Commitment Fee AmortizationAssociatedWithCommitmentFee	15385	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	476075	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	870000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	139542	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1485617	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	132514000
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0555
CY2022	crtg	Class Of Warrant Or Right Contractual Term ClassOfWarrantOrRightContractualTerm	P3Y7M17D
CY2023	crtg	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	12500000
CY2023	crtg	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.0001
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	120014000
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0612
CY2023	crtg	Class Of Warrant Or Right Contractual Term ClassOfWarrantOrRightContractualTerm	P2Y7M17D
CY2023Q4	crtg	Class Of Warrant Or Right Intrinsic Value ClassOfWarrantOrRightIntrinsicValue	843780	usd
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21500000
CY2020Q2	crtg	Share Exchange Agreement Exchange Ratio ShareExchangeAgreementExchangeRatio	0.6	pure
	crtg	Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged	9500000
	crtg	Stock Issued During Period Shares Stock Options Exchanged For Common Shares StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares	5700000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	24000000
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0277
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	24000000
CY2023Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0235
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	564000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	761695	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	101158160
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P3Y2M19D
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	101158160
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	54600	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	41175	usd

Files In Submission

Name	View Source	Status
0001437749-24-008792-index-headers.html	Edgar Link	pending
0001437749-24-008792-index.html	Edgar Link	pending
0001437749-24-008792.txt	Edgar Link	pending
0001437749-24-008792-xbrl.zip	Edgar Link	pending
crtg-20231231.xsd	Edgar Link	pending
crtg20231231_10k.htm	Edgar Link	pending
crtg20231231_10kimg001.jpg	Edgar Link	pending
ex_637343.htm	Edgar Link	pending
ex_637344.htm	Edgar Link	pending
ex_637345.htm	Edgar Link	pending
ex_637346.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
crtg-20231231_cal.xml	Edgar Link	unprocessable
crtg-20231231_def.xml	Edgar Link	unprocessable
crtg-20231231_lab.xml	Edgar Link	unprocessable
crtg-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crtg20231231_10k_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTG
CORETEC GROUP INC. Stock $crtg

2024 Q1 Form 10-K Financial Statement

#000143774924008792 Filed on March 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTG CORETEC GROUP INC. Stock $crtg

2024 Q1 Form 10-K Financial Statement

#000143774924008792 Filed on March 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTG
CORETEC GROUP INC. Stock $crtg